Published in Medicine and Law Weekly, August 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Omnicell.
Report 1: Omnicell, Inc. (NASDAQ: OMCL), a leading provider of patient safety technology, announced today the pricing of an underwritten public offering of 3,900,000 shares of its common stock at a public offering price of $21.50 per share. Omnicell has granted the underwriters a 30-day option to purchase up to an additional 585,000 shares of common stock to cover over-allotments, if any.
Report 2: Omnicell, Inc. (OMCL) is the recipient of M2M Magazine's 2006 Silver...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly